Skip to main content

Table 1 Patient characteristics

From: Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters

Variables

No. of patients (%)

Gender

 

  Male

74 (80.4)

  Female

18 (19.6)

Age (years)

 

  Median

61

  Range

42–86

ECOG performance score

 

  0–1

89 (96.7)

  2

3 (3.3)

Child-Pugh class

 

  A

68 (73.9)

  B

24 (26.1)

Viral etiology

 

  HBs-Ag (+)

69 (75.0)

  HBs-Ag (-)

23 (25.0)

Tumor volume (cm3)

 

  Median

8.6

  Range

0.6–125.3

Previous treatments

 

  None

1 (1.1)

  TACE

47 (51.1)

  TACE, RFA

21 (22.8)

  TACE, PEIT

4 (4.3)

  TACE, RFA, PEIT

2 (2.2)

  Resection

1 (1.1)

  Resection, TACE

11 (11.9)

  Resection, TACE, RFA

2 (2.2)

  Resection, TACE, PEIT

1 (1.1)

  RFA

2 (2.2)

  1. Abbreviations: ECOG Eastern Cooperative Oncology Group, HBs-Ag hepatitis B surface-antigen, TACE transarterial chemoembolization, RFA radiofrequency ablation, PEIT percutaneous ethanol injection treatment.